EZZ Life Science Holdings Limited (ASX:EZZ)
Australia
· Delayed Price · Currency is AUD 1.580
+0.080 (5.33%)
Apr 16, 2025, 4:10 PM AEST
EZZ Life Science Holdings Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 |
| Operating Revenue | 75.03 | 66.44 | 37.14 | 15.02 | 22.29 | 17.32 | Upgrade
|
| Other Revenue | - | - | - | - | - | 0.65 | Upgrade
|
| Revenue | 75.03 | 66.44 | 37.14 | 15.02 | 22.29 | 17.97 | Upgrade
|
| Revenue Growth (YoY) | 71.65% | 78.88% | 147.26% | -32.60% | 24.03% | 60.62% | Upgrade
|
| Cost of Revenue | 16.09 | 15.5 | 8.61 | 7.51 | 9.83 | 13.29 | Upgrade
|
| Gross Profit | 58.95 | 50.95 | 28.53 | 7.51 | 12.46 | 4.68 | Upgrade
|
| Selling, General & Admin | 43.28 | 38.49 | 21.7 | 4.14 | 8.68 | 2.17 | Upgrade
|
| Other Operating Expenses | 2 | 2.35 | 2.03 | 1.46 | 0.9 | 0.21 | Upgrade
|
| Operating Expenses | 46.16 | 41.23 | 23.91 | 5.72 | 9.71 | 2.52 | Upgrade
|
| Operating Income | 12.79 | 9.72 | 4.62 | 1.78 | 2.75 | 2.16 | Upgrade
|
| Interest Expense | -0.02 | -0.02 | -0.01 | -0 | -0.01 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.35 | 0.2 | 0.04 | 0 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.07 | 0.07 | 0.22 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | 0.04 | - | - | - | Upgrade
|
| Pretax Income | 13.19 | 9.96 | 4.9 | 1.78 | 2.74 | 2.15 | Upgrade
|
| Income Tax Expense | 4.17 | 2.99 | 1.27 | 0.47 | 0.71 | 0.56 | Upgrade
|
| Net Income | 9.02 | 6.96 | 3.63 | 1.31 | 2.03 | 1.59 | Upgrade
|
| Net Income to Common | 9.02 | 6.96 | 3.63 | 1.31 | 2.03 | 1.59 | Upgrade
|
| Net Income Growth | 159.71% | 91.87% | 176.57% | -35.37% | 28.02% | 92.54% | Upgrade
|
| Shares Outstanding (Basic) | 44 | 43 | 43 | 43 | 34 | 30 | Upgrade
|
| Shares Outstanding (Diluted) | 44 | 43 | 43 | 43 | 34 | 30 | Upgrade
|
| Shares Change (YoY) | 3.97% | 0.89% | 0.46% | 25.23% | 13.15% | - | Upgrade
|
| EPS (Basic) | 0.20 | 0.16 | 0.08 | 0.03 | 0.06 | 0.05 | Upgrade
|
| EPS (Diluted) | 0.20 | 0.16 | 0.08 | 0.03 | 0.06 | 0.05 | Upgrade
|
| EPS Growth | 149.76% | 90.19% | 175.31% | -48.37% | 13.10% | - | Upgrade
|
| Free Cash Flow | 7.92 | 5.73 | 3.91 | 1.9 | 0.25 | 2.88 | Upgrade
|
| Free Cash Flow Per Share | 0.18 | 0.13 | 0.09 | 0.04 | 0.01 | 0.10 | Upgrade
|
| Dividend Per Share | 0.020 | 0.035 | 0.020 | 0.004 | 0.004 | - | Upgrade
|
| Dividend Growth | -20.00% | 76.77% | 340.00% | - | - | - | Upgrade
|
| Gross Margin | 78.56% | 76.68% | 76.81% | 49.98% | 55.90% | 26.05% | Upgrade
|
| Operating Margin | 17.05% | 14.62% | 12.43% | 11.88% | 12.33% | 12.00% | Upgrade
|
| Profit Margin | 12.02% | 10.48% | 9.77% | 8.74% | 9.11% | 8.83% | Upgrade
|
| Free Cash Flow Margin | 10.55% | 8.63% | 10.53% | 12.62% | 1.11% | 16.05% | Upgrade
|
| EBITDA | 12.87 | 9.75 | 4.63 | 1.8 | 2.76 | 2.18 | Upgrade
|
| EBITDA Margin | 17.16% | 14.68% | 12.48% | 11.98% | 12.41% | 12.13% | Upgrade
|
| D&A For EBITDA | 0.08 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| EBIT | 12.79 | 9.72 | 4.62 | 1.78 | 2.75 | 2.16 | Upgrade
|
| EBIT Margin | 17.05% | 14.62% | 12.43% | 11.88% | 12.33% | 12.00% | Upgrade
|
| Effective Tax Rate | 31.63% | 30.07% | 25.93% | 26.26% | 25.80% | 26.22% | Upgrade
|
| Advertising Expenses | - | 37.23 | 20.56 | 2.97 | 7.84 | 1.55 | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.